Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time

Journal of Virology

Volumn 84, Issue 14, 2010, Pages 7195-7203

  Görzer, Irene ^a   Guelly, Christian ^b   Trajanoski, Slave ^b   Puchhammer Stöckl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; GLYCOPROTEIN; GLYCOPROTEIN N; GLYCOPROTEIN O; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ARTICLE; CLINICAL ARTICLE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CYTOMEGALOVIRUS; LUNG TRANSPLANTATION; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UL139 GENE; VIRUS GENE; VIRUS LOAD;

ANIMALS; BASE SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GENOTYPE; HUMANS; LUNG TRANSPLANTATION; MICE; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL LOAD;

HUMAN HERPESVIRUS 5; MURINAE;

EID: 77953734114     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00475-10     Document Type: Article

References (53)

1. Böhm, V., C. K. Seckert, C. O. Simon, D. Thomas, A. Renzaho, D. Gendig, R. Holtappels, and M. J. Reddehase. 2009. Immune evasion proteins enhance cytomegalovirus latency in the lungs. J. Virol. 83:10293-10298.
2. Boppana, S. B., L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt. 2001. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344:1366-1371.
3. Bradley, A. J., I. J. Kovacs, D. Gatherer, D. J. Dargan, K. R. Alkharsah, P. K. Chan, W. F. Carman, M. Dedicoat, V. C. Emery, C. C. Geddes, G. Gerna, B. Ben-Ismaeil, S. Kaye, A. McGregor, P. A. Moss, R. Pusztai, W. D. Rawlinson, G. M. Scott, G. W. Wilkinson, T. F. Schulz, and A. J. Davison. 2008. Genotypic analysis of two hypervariable human cytomegalovirus genes. J. Med. Virol. 80:1615-1623.
4. Burkhardt, C., S. Himmelein, W. Britt, T. Winkler, and M. Mach. 2009. Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection. J. Gen. Virol. 90:1951-1961.
5. Chang, W. L., P. A. Barry, R. Szubin, D. Wang, and N. Baumgarth. 2009. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330-337.
6. Chmiel, C., R. Speich, M. Hofer, D. Michel, T. Mertens, W. Weder, and A. Boehler. 2008. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin. Infect. Dis. 46:831-839.
7. Cicin-Sain, L., J. Podlech, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 2005. Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J. Virol. 79:9492-9502. (Pubitemid 41022293)
8. Cunningham, C., D. Gatherer, B. Hilfrich, K. Baluchova, D. J. Dargan, M. Thomson, P. D. Griffiths, G. W. Wilkinson, T. F. Schulz, and A. J. Davison. 2010. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J. Gen. Virol. 91:605-615.
9. Dolan, A., C. Cunningham, R. D. Hector, A. F. Hassan-Walker, L. Lee, C. Addison, D. J. Dargan, D. J. McGeoch, D. Gatherer, V. C. Emery, P. D. Griffiths, C. Sinzger, B. P. McSharry, G. W. Wilkinson, and A. J. Davison. 2004. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85:1301-1312.
10. Dunn, W., C. Chou, H. Li, R. Hai, D. Patterson, V. Stolc, H. Zhu, and F. Liu. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
11. Freeman, R. B., Jr. 2009. The 'indirect' effects of cytomegalovirus infection. Am. J. Transplant. 9:2453-2458.
12. Gandhi, M. K., and R. Khanna. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4:725-738.
13. Gleaves, C. A., and J. D. Meyers. 1989. Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens from marrow transplant patients: evaluation of a direct fluorescein-conjugated monoclonal antibody reagent. J. Virol. Methods 26:345-349.
14. Görzer, I., H. Kerschner, P. Jaksch, C. Bauer, G. Seebacher, W. Klepetko, and E. Puchhammer-Stöckl. 2008. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J. Med. Virol. 80:1405-1414.
15. Hahn, G., M. G. Revello, M. Patrone, E. Percivalle, G. Campanini, A. Sarasini, M. Wagner, A. Gallina, G. Milanesi, U. Koszinowski, F. Baldanti, and G. Gerna. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033.
16. Heo, J., S. Petheram, G. Demmler, J. R. Murph, S. P. Adler, J. Bale, and T. E. Sparer. 2008. Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 378:86-96.
17. Humar, A., D. Kumar, C. Gilbert, and G. Boivin. 2003. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solidorgan-transplant recipients with CMV disease. J. Infect. Dis. 188:581-584.
18. Husain, S., C. E. Pietrangeli, and A. Zeevi. 2009. Delayed onset CMV disease in solid organ transplant recipients. Transpl. Immunol. 21:1-9.
19. Huse, S. M., J. A. Huber, H. G. Morrison, M. L. Sogin, and D. M. Welch. 2007. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 8:R143.
20. Ishibashi, K., T. Tokumoto, H. Shirakawa, K. Hashimoto, N. Kushida, T. Yanagida, K. Shishido, K. Aikawa, O. Yamaguchi, H. Toma, K. Tanabe, and T. Suzutani. 2008. Strain-specific seroepidemiology and reinfection of cytomegalovirus. Microbes Infect. 10:1363-1369.
21. Kurz, S. K., and M. J. Reddehase. 1999. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J. Virol. 73:8612-8622.
22. Lurain, N. S., A. M. Fox, H. M. Lichy, S. M. Bhorade, C. F. Ware, D. D. Huang, S. P. Kwan, E. R. Garrity, and S. Chou. 2006. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol. J. 3:4.
23. Manuel, O., A. Asberg, X. Pang, H. Rollag, V. C. Emery, J. K. Preiksaitis, D. Kumar, M. D. Pescovitz, A. A. Bignamini, A. Hartmann, A. G. Jardine, and A. Humar. 2009. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin. Infect. Dis. 49:1160-1166.
24. Mattick, C., D. Dewin, S. Polley, E. Sevilla-Reyes, S. Pignatelli, W. Rawlinson, G. Wilkinson, P. Dal Monte, and U. A. Gompels. 2004. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 318:582-597.
25. McGeoch, D. J., F. J. Rixon, and A. J. Davison. 2006. Topics in herpesvirus genomics and evolution. Virus Res. 117:90-104.
26. Meyer-Konig, U., K. Ebert, B. Schrage, S. Pollak, and F. T. Hufert. 1998. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280-1281. (Pubitemid 28470344)
27. Novak, Z., S. A. Ross, R. K. Patro, S. K. Pati, R. A. Kumbla, S. Brice, and S. B. Boppana. 2008. Cytomegalovirus strain diversity in seropositive women. J. Clin. Microbiol. 46:882-886.
28. Pang, X., A. Humar, and J. K. Preiksaitis. 2008. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J. Clin. Microbiol. 46:4004-4010.
29. Patel, R., and C. V. Paya. 1997. Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10:86-124.
30. Pignatelli, S., P. Dal Monte, and M. P. Landini. 2001. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J. Gen. Virol. 82:2777-2784.
31. Pignatelli, S., P. Dal Monte, G. Rossini, S. Chou, T. Gojobori, K. Hanada, J. J. Guo, W. Rawlinson, W. Britt, M. Mach, and M. P. Landini. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J. Gen. Virol. 84:647-655.
32. Pignatelli, S., P. Dal Monte, G. Rossini, and M. P. Landini. 2004. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol. 14:383-410.
33. Puchhammer-Stöckl, E., and I. Görzer. 2006. Cytomegalovirus and Epstein-Barr virus subtypes-the search for clinical significance. J. Clin. Virol. 36:239-248.
34. Puchhammer-Stöckl, E., I. Görzer, A. Zoufaly, P. Jaksch, C. C. Bauer, W. Klepetko, and T. Popow-Kraupp. 2006. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 81:187-194.
35. Rasmussen, L., A. Geissler, C. Cowan, A. Chase, and M. Winters. 2002. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J. Virol. 76:10841-10848. (Pubitemid 35176201)
36. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
37. Reddehase, M. J., C. O. Simon, C. K. Seckert, N. Lemmermann, and N. K. Grzimek. 2008. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:315-331.
38. Reeves, M., and J. Sinclair. 2008. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:297-313.
39. Reeves, M. B., P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86:2949-2954.
40. Reeves, M. B., P. A. MacAry, P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
41. Reeves, M. B., and J. H. Sinclair. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91:599-604.
42. Simon, C. O., C. K. Seckert, D. Dreis, M. J. Reddehase, and N. K. Grzimek. 2005. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J. Virol. 79:326-340.
43. Sinclair, J. 2010. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 1799:286-295.
44. Sitki-Green, D., M. Covington, and N. Raab-Traub. 2003. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J. Virol. 77:1840-1847. (Pubitemid 36109996)
45. Stanton, R., D. Westmoreland, J. D. Fox, A. J. Davison, and G. W. Wilkinson. 2005. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. J. Med. Virol. 75:42-46.
46. Streblow, D. N., S. L. Orloff, and J. A. Nelson. 2007. Acceleration of allograft failure by cytomegalovirus. Curr. Opin. Immunol. 19:577-582.
47. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
48. Tarrago, D., C. Quereda, and A. Tenorio. 2003. Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J. Clin. Microbiol. 41:2872-2877.
49. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
50. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
51. Wang, C., Y. Mitsuya, B. Gharizadeh, M. Ronaghi, and R. W. Shafer. 2007. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 17:1195-1201.
52. Wang, D., and T. Shenk. 2005. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J. Virol. 79:10330-10338. (Pubitemid 41098573)
53. Zamora, M. R. 2004. Cytomegalovirus and lung transplantation. Am. J. Transplant. 4:1219-1226.